The mammalian immune system has developed surveillance mechanisms that can detect cancerous cells. However successful tumor cells have evolved strategies to evade detection. Current therapeutic strategies focus on improving cancer cell recognition and tumor elimination. Both immunocompetent and immunodeficient mouse models have been instrumental in the development of these therapies.
In this webinar you will learn about:
Registration is Open